Lung Cancer Awareness: Genomic Insights
Search Result (lung cancer)
- CDC Resources
- CDC Web Information (2)
- CDC-Authored Genomics Publications (7)
- Discoveries and Insights
- Hot Topics (53)
- Health Impact Scan (6)
- Relevant Resources (2)
- Epidemiology
- Human Genome Epidemiology (3466)
- Relevant Resources (1)
- Translational Research
- Health Impact Scan (42)
- Evidence Synthesis
- Guidelines (8)
- Evidence Classification (4)
- Health Impact Scan (14)
- Relevant Resources (1)
- Practice and Implementation
- Health Impact Scan (3)
- Relevant Resources (5)
A family health history of lung cancer is a risk factor for lung cancer  |
| What you can do to lower your lung cancer risk |
| Circulating free DNA concentration is an independent prognostic biomarker in lung cancer. Tissot Claire et al. The European respiratory journal 2015 Oct (Time Posted: Oct-25-2015 8PM) |
| Emerging platforms using liquid biopsy to detect EGFR mutations in lung cancer. Lin Chien-Chung et al. Expert review of molecular diagnostics 2015 Sep 1-14 (Time Posted: Oct-25-2015 8PM) |
| Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions. Zhang Zhuo et al. Frontiers in oncology 2015 209 (Time Posted: Oct-25-2015 8PM) |
| FDA Approval Gives More Lung Cancer Patients Immunotherapy Option K Honey, AACR Blog Post, October 12, 2015 (Time Posted: Oct-13-2015 11AM) |
| Somatic Mutation Spectrum of Non–Small-Cell Lung Cancer in African Americans: A Pooled Analysis A Luiz et al. J Thoracic Oncology, October 2015 (Time Posted: Oct-11-2015 10PM) |
| Observational and genetic plasma YKL-40 and cancer in 96,099 individuals from the general population. International journal of cancer. Journal international du cancer 2015 Dec 137 (11): 2696-704. Kjaergaard Alisa D, Nordestgaard Børge G, Johansen Julia S, Bojesen Stig |
| The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer. International journal of cancer. Journal international du cancer 2015 Nov 137 (10): 2332-42. Butkiewicz Dorota, Krze?niak Ma?gorzata, Drosik Anna, Giglok Monika, Gdowicz-K?osok Agnieszka, Kosarewicz Agata, Rusin Marek, Mas?yk Barbara, Gawkowska-Suwi?ska Marzena, Suwi?ski Raf |
| [Detection and Analysis of EGFR and KRAS Mutations ?in the Patients with Lung Squamous Cell Carcinomas]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2015 Oct 18 (10): 621-5. Zhang Hui, Yang Xinjie, Qin Na, Li Xi, Yang Huiyi, Nong Jingying, Lv Jialin, Wu Yuhua, Zhang Quan, Zhang Xinyong, Wang Jinghui, Su Dan, Zhang Shuc |
| Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2015 Oct 10 (10): 1451-7. Gautschi Oliver, Milia Julie, Cabarrou Bastien, Bluthgen Marie-Virginia, Besse Benjamin, Smit Egbert F, Wolf Juergen, Peters Solange, Früh Martin, Koeberle Dieter, Oulkhouir Youssouf, Schuler Martin, Curioni-Fontecedro Alessandra, Huret Benjamin, Kerjouan Mallorie, Michels Sebastian, Pall Georg, Rothschild Sacha, Schmid-Bindert Gerald, Scheffler Matthias, Veillon Rémi, Wannesson Luciano, Diebold Joachim, Zalcman Gérard, Filleron Thomas, Mazières Juli |
| The role of NOD1/CARD4 and NOD2/CARD15 genetic variations in lung cancer risk. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2015 Oct 64 (10): 775-9. Ozbayer Cansu, Kurt Hulyam, Bayramoglu Aysegul, Gunes Hasan Veysi, Metintas Muzaffer, Degirmenci ?rfan, Oner Kevser Seten |
| Publication | Product Type |
|---|---|
| The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study. Carere Deanna Alexis, et al. BMC medical genomics 2015 0 0. (1) 63 | Original Studies |
| EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital Trust. Berg Janna, et al. Acta Oncol 2015 8 27. 1-7 | Original Studies |
| Targeted Cancer Screening in Average-Risk Individuals. Marcus Pamela M, et al. Am J Prev Med 2015 7 9. | Original Studies |
| Patients with Non-small Cell Lung Cancer Analyzed for EGFR: Adherence to Guidelines, Prevalence and Outcome. Sandelin Martin, et al. Anticancer Res. 2015 7 0. (7) 3979-85 | Original Studies |
| Combining three antibodies nullifies feedback-mediated resistance to erlotinib in lung cancer Maicol Mancini, et al. Sci. Signal., 2 June 2015 | Original Studies |
| National Working Group Meeting on ALK diagnostics in lung cancer. Published 2014 (Pfizer-sponsored National Working Group Meeting on ALK Diagnostics in Lung Cancer) |
| Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Published 2015 (American Society of Clinical Oncology (ASCO)) |
| Final Recommendation Statement: Lung Cancer: Screening, December 2013 Published 2013 (US Preventive Services Task Force) |
| EGFR-TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer Published 2013 (National Institute for Health and Care Excellence) |
| Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group. Published 2013 (Korean Cardiopulmonary Pathology Study Group) |
| Publication | Product Type |
|---|---|
| Sputum microRNA Biomarkers for Identifying Lung Cancer in Indeterminate Solitary Pulmonary Nodules. Xing Lingxiao, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 1 (2) 484-9 | Tools/ Concepts/Methods / Training / Education/ Decision Support |
| Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era. Brothers JF, et al. BMC medicine 2013 7 | Tools/ Concepts/Methods / Training / Education/ Decision Support |
| DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): a catalog of clinically relevant cancer mutations to enable genome-directed anticancer therapy. Yeh P, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 4 (7) 7 | Tools/ Concepts/Methods / Training / Education/ Decision Support |
.png)
No hay comentarios:
Publicar un comentario